CandySeift

Over the past decades, Creative Biolabs has become a leader in antibody drug discovery and manufacturing, providing high quality services to clients in academia and industry around the world. Now, we are able to provide solutions to accelerate drug discovery and development by deploying artificial intelligence technologies. Here, we will briefly introduce the basics of AI-augmented drug discovery, algorithm classification, common AI models, and related services. https://ai.creative-biolabs.com/

CellRapeutics™ chimeric antigen receptor (CAR) technology platform can perform well in CAR-T cell glycosylation and Luminex assay for monitoring CAR-T cytokine profiles. https://www.creative-biolabs.com/car-t/cellrapeutics-chimeric-antigen-receptor-car-technology.htm

Delivery Systems for Gene Therapy covers bacteria, dendritic cell, stem cell, denfrimer, polyplexes, viral vector, etc. https://www.creative-biolabs.com/gene-therapy/delivery-systems-development-for-gene-therapy.htm

Creative Biolabs focuses on neutralizing antibody development and functional peptide discovery for viral diseases to support diagnostic and therapeutic purposes. https://www.creative-biolabs.com/antinfect/antibody-peptide-discovery-for-viral-disease.htm

Creative Biolabs is the leading custom service provider in antibody development and engineering. Our scientists bring state-of-the-art technology to support functional antibody and peptide discovery services against viruses. https://www.creative-biolabs.com/antinfect/

One of the key steps in gene therapy is to deliver foreign genes or gene editing systems into target tissues or cells. Thus efficient gene delivery system is very important to the effect of gene therapy. https://www.creative-biolabs.com/gene-therapy/

Oncolytic viruses（OVs） are viral strains that can infect and kill malignant cells without harming normal cells, while simultaneously stimulate the immune system and creating system antitumor immunity. https://www.creative-biolabs.com/oncolytic-virus/

This video briefly introduced why CAR T cell validation assay is essential for car t therapy development and which assays should be done to validate the safety, identity, purity and potency of car t cell products. https://www.creative-biolabs.com/car-t/

Creative Biolabs, established in the US, is a leading contract service provider of bispecific antibody discovery and engineering. https://www.creative-biolabs.com/bsab/

Key webinar highlights: Recognizing the "friend or foe" relationship between (blood) cancer and immunityLeveraging on the immunotherapies for malignant and nonmalignant (hematological) tumorsNeed for next-generation immune monitoring https://www.creative-biolabs.com/bsab/new-ways-of-evaluating-the-tumor-immune-microenvironment-from-bench-to-bedside.htm

Creative Biolabs invited Dr. Bruno Paiva to give us a clearer understanding of novel immunotherapies and the combined methods to be applied in the research of tumorigenesis and drug development. https://www.creative-biolabs.com/bsab/new-ways-of-evaluating-the-tumor-immune-microenvironment-from-bench-to-bedside.htm